The use of biochemical and molecular parameters to estimate dose-response relationships at low levels of exposure

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 1, 1998, Pages 349-355

  Andersen, Melvin E ^a   Barton, Hugh A ^a  

^a ICF Kaiser Engineers Inc   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin; Dose response relationship; Exposure biomarkers; Markers of tumor promotion; Response biomarkers; Response curves; TCDD; U shaped curves

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; BIOLOGICAL MARKER; CYTOCHROME A;

CELL PROLIFERATION; CONFERENCE PAPER; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; LIVER PARENCHYMA; LIVER TUMOR; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0031968296     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106s1349     Document Type: Conference Paper

References (36)

1. U.S. EPA. Proposed guidelines for carcinogen risk assessment. EPA 600-P-92-003C. Washington: U.S. Environmental Protection Agency Office of Research and Development, 1996.
2. Kociba RJ, Keyes DG, Beyer JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Frauson LE, Park CN, Banard SD et al. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol 120:138-154 (1978).
3. U.S. NTP. Carcinogenesis Bioassay of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (CAS No. 1746-01-6) in Osborne-Mendel Rats and B6C3F1 Mice (Gavage Study). Tech Rpt No 209. Research Triangle Park, NC:U.S. National Toxicology Program, 1982.
4. Abbott BD, Birnbaum LS, Pratt RM. 2,3,7,8-TCDD-induced hyperplasia of the ureteral epithelium produces hydronephrosis in murine fetuses. Teratology 35:3219-3233 (1987).
5. Burelson GR, Lebrec H, Yang YG, Ibanes JD, Pennington KN, Birnbaum LS. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenze virus host resistance in mice. Fundam Appl Toxicol 29:40-47 (1996).
6. Mably TA, Bjerke DL, Moore RW, Gendron-Fitzpatric A, Person RE. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 3: Effects of spermatogenesis and reproductive capability. Toxicol Appl Pharmacol 114:118-128 (1993).
7. Gray LE Jr, Kelce WR, Monosson E, Ostby JS, Birnbaum LS. Exposure to TCDD during development permanently alters reproductive function in male Long Evans rats and hamsters: reduced ejaculated and epididymal sperm numbers and sex accessory gland weights in offspring with normal androgenic status. Toxicol Appl Pharmacol 131:108-118 (1995).
8. Perdew G. Chemical cross-linking of the cytosolic and nuclear forms of the Ah receptor in hepatoma cell line 1C1C7. Biochem Biophys Res Comm 182:55-63 (1992).
9. Swanson HI, Bradfield CA. The Ah-receptor: genetics, structure and function. Pharmacogenetics 3:213-230 (1993).
10. Reyes H, Reisz-Porszasz S, Hankinson O. Identification of the Ah receptor nuclear translocator protein (arnt) as a component of the DNA binding form of the Ah receptor. Science 256:1193-1195 (1992).
11. Quattrochi LC, Vu T, Tukey RH. The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA supoorts Ah-receptor binding and promoter-specific induction. J Biol Chem 269:6949-6954 (1994).
12. Pitot H, Goldsworthy TL, Moran S, Kennan W, Glauert HP, Maronpot RR, Campbell HA. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis 8:1491-1499 (1987).
13. van Birgelen APJM, DeVito MJ, Akins JM, Ross DG, Diliberto JJ, Birnbaum LS. Relative potencies of polychlorinated dibenzo-p-dioxins, dibenzofurans and biphenyls derived from hepatic porphyrin accumulation in mice. Toxicol Appl Pharmacol 138:98-109 (1996).
14. Jacobs JM, Sinclair PR, Bernent WJ, Lambrecht RW, Sinclair JF, Goldstein JA. Oxidation of uroprophyrinogen by methycholanthrene-induced cytochrome P-450. Essential role of cytochrome P450d. Biochem J 258:247-253 (1989).
15. Maronpot RR, Foley JF, Takahashi K, Goldsworthy T, Clark G, Trischer A, Portier C, Lucier G. Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic, biochemical and cell proliferation end points. Environ Health Perspect 101:634-642 (1993).
16. Stinchcombe S, Buchmann A, Bock KW, Schwarz M. Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-pdioxin-mediated tumour promotion in rat liver. Carcinogenesis 16:1271-1275 (1995).
17. Vanden Heuvel JP, Clark GC, Kohn MC, Tritscher AM, Greenlee WF, Lucier GW, Bell DA. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res 54:62-68 (1994).
18. Bars RG, Elcombe CR. Dose-dependent acinar induction of cytochromes P450 in rat liver: evidence for a differential mechanism of induction of P450IA1 by β-naphthoflavone and dioxin. Biochem J 277:577-580 (1991).
19. Tritscher M, Goldstein JA, Portier CJ, McCoy Z, Clark GC, Lucier GW. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer Res 52:3436-3442 (1992).
20. Leung HW, Ku RH, Paustenbach DJ, Andersen ME. A physiologically based pharmacokinetic model for 2,3,7,8-tetrachloro-p-dioxin in C57B1/6J and DBA/2J mice. Toxicol Lett 42:15-28 (1988).
21. Leung HW, Pausteabach DJ, Murray FJ, Andersen ME. A physiological pharmacokinetic description of the tissue distribution and enzyme inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Toxicol Appl Pharmacol 103:399-410 (1990).
22. Kohn MC, Lucier GW, Clark GC, Sewall C, Tritscher A, Portier CJ. A mechanistic model of the effects of dioxin on gene expression in the rat liver. Toxicol Appl Pharmacol 120:138-154 (1993).
23. Kedderis LB, Mills JJ, Andersen ME, Birnbaum LS. A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: tissue distribution and CYP1A induction. Toxicol Appl Pharmacol 121:87-98 (1993).
24. Andersen ME, Mills JJ, Gargas ML, Kedderis L, Birnbaum LS, Neubert D, Greenlee WF. Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment. J Risk Anal 13:25-36 (1993).
25. Andersen ME, Eklund CR, Mills JJ, Barton HA, Birnbaum LS. A multi-compartment geometric model of the liver in relation to regional induction of cytochrome P450s. Toxicol Appl Pharmacol 144:135-144 (1997).
26. Andersen ME, Birnbaum LS, Barton HA, Eklund CR. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multi-compartment geometric model of hepatic zonation. Toxicol Appl Pharmacol 144:145-155 (1997).
27. Fox TR, Best LL, Goldsworthy SM, Mills JJ, Goldsworthy TL. Gene expression and cell proliferation in rat liver after 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure. Cancer Res 53:2265-2271 (1993).
28. Bauman JW, Goldsworthy TL, Dunn CS, Fox TR. Inhibitory effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on rat hepatocyte proliferation induced by 2/3 partial hepatectomy. Cell Prolif 28:437-451 (1995).
29. Portier CJ, Kohn MC, Kopp-Schneider A, Sherman CD, Maronpot R, Lucier GW. Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD. Toxicol Appl Pharmacol 138:20-30 (1996).
30. Moolgavkar SH, Luebeck EG, Buchmann A, Bock KW. Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 138:31-42 (1996).
31. Rogers A, Andersen ME, Back KG. Mutagenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin and perfluorodecanoic acid LS178Y mouse lymphoma cells. Mutat Res 105:445-449 (1982).
32. Yang J-H, Thraves P, Dritschilo A, Rhim JS. Neoplastic transformation of immortalized human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res 52:3478-3482 (1992).
33. Andersen ME, Mills JJ, Jirtle RL, Greenlee WF. Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology 102:223-237 (1995).
34. Conolly RB, Andersen ME. Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: evaluation of a quantitative two-cell model and of CYP1A1/1A2 as a dosimeter. Toxicol Appl Pharmacol 146:281-293 (1997).
35. Jirtle RL, Meyer SA, Brockenbrough JS. Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation. In: Chemically Induced Cell Proliferation: Implications for Risk Assessment (Butterworth B, Slaga TJ, Farland W, McClain M, eds). Vol 369. New York:Wiley-Liss, 1991; 209-216.
36. Pitot H. Personal communication.